UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________________

FORM SD

Specialized Disclosure Report

____________________________

NEVRO CORP.

(Exact name of registrant as specified in its charter)

____________________________

Kashif Rashid

General Counsel

650-433-3950

(Name and telephone number, including area code, of the person to contact in connection with this report.)

____________________________

Check the appropriate box to indicate the rule pursuant to which this form is being filed:

☒ Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2022.

N/A Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended _____.

1

Section 1—Conflict Minerals Disclosure

Item 1.01 Conflict Minerals Disclosure and Report

This Specialized Disclosure Report on Form SD (“Form SD”) of Nevro Corp. (“Nevro”) is filed pursuant to Rule 13p-1 promulgated under the Securities Exchange Act of 1934 for the reporting period of January 1, 2022 to December 31, 2022.

A copy of Nevro’s Conflict Minerals Report is provided as Exhibit 1.01 to this Form SD and is publicly available at http://www.nevro.com/English/About-Us/Corporate-Governance/default.aspx.

Item 1.02 Exhibit

As specified in Section 3, Item 3.01 of this Form SD, Nevro is hereby filing its Conflict Minerals Report as Exhibit 1.01.

Section 2 – Resource Extraction Issuer Disclosure

Not applicable

Section 3—Exhibit

The attached Exhibit 1.01, entitled “Nevro Corp. Conflict Minerals Report: For the Period from January 1, 2022 to December 31, 2022” is filed as an exhibit to this Form SD report.

Item 3.01 Exhibit

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

2